Join McDermott Will & Schulte’s Life Sciences Investment Forum November 12–13 in Boston, bringing together

private equity, growth equity, and later-stage venture investors, growth-stage company executives, and industry advisors to discuss the current dealmaking environment, from M&A and financing strategies to regulatory developments and commercial growth.

The program offers opportunities to connect with peers across the industry and gain insight into where life sciences dealmaking is headed.

New this year: a CLE program specifically for life sciences in-house legal and compliance teams on Friday, November 13, from 8:30 am to 1:00 pm.

A limited number of complimentary passes are available for MassBio members. To confirm availability, please contact the Life Sciences Investment Forum BD team.